United States · FDA National Drug Code directory
VISTOGARD
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50633-220_4e4e69bd-abb4-4632-e063-6394a90ab642
- Product NDC
- 50633-220
- Form
- GRANULE
- Composition / generic term
- uridine triacetate
- Labeler
- BTG International Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240731
- Source listing expiry
- 20271231
Source-listed ingredients
- URIDINE TRIACETATE — 951 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 4 PACKET in 1 CARTON (50633-220-04) / 10 g in 1 PACKET (50633-220-10) · 50633-220-04
- 20 PACKET in 1 CARTON (50633-220-20) / 10 g in 1 PACKET (50633-220-10) · 50633-220-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →